1. Home
  2. SCLX vs DCGO Comparison

SCLX vs DCGO Comparison

Compare SCLX & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$5.86

Market Cap

55.1M

Sector

Health Care

ML Signal

N/A

Logo DocGo Inc.

DCGO

DocGo Inc.

N/A

Current Price

$0.43

Market Cap

63.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
DCGO
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.1M
63.5M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
SCLX
DCGO
Price
$5.86
$0.43
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.38
AVG Volume (30 Days)
59.5K
761.9K
Earning Date
04-10-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,253,000.00
$322,196,000.00
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
$6.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$0.40
52 Week High
$34.27
$1.73

Technical Indicators

Market Signals
Indicator
SCLX
DCGO
Relative Strength Index (RSI) 33.68 34.92
Support Level $5.48 N/A
Resistance Level $7.77 $0.67
Average True Range (ATR) 0.42 0.05
MACD -0.08 -0.03
Stochastic Oscillator 13.24 12.39

Price Performance

Historical Comparison
SCLX
DCGO

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

Share on Social Networks: